(Q33215101)

English

Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 July 2017

Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects (English)

1 reference

Europe PubMed Central

24 July 2017

author name string

Kissel T

1

1 reference

Europe PubMed Central

24 July 2017

Drewe J

2

1 reference

Europe PubMed Central

24 July 2017

Bantle S

3

1 reference

Europe PubMed Central

24 July 2017

Rummelt A

4

1 reference

Europe PubMed Central

24 July 2017

Beglinger C

5

1 reference

Europe PubMed Central

24 July 2017

publication date

1 January 1992

1 reference

Europe PubMed Central

24 July 2017

Pharmaceutical Research

1 reference

Europe PubMed Central

24 July 2017

9

1 reference

Europe PubMed Central

24 July 2017

1

1 reference

Europe PubMed Central

24 July 2017

52-57

1 reference

Europe PubMed Central

24 July 2017

Somatostatin and its analogues in the therapy of gastrointestinal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide, a new somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition of sandostatin, a new synthetic somatostatin analogue, in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of absorption enhancers on human nasal tissue ciliary movement in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Transnasal administration of drugs. 2. Models for studying nasal absorption in animals and parameters susceptible to influence]

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of bile salts on nasal permeability in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: a scanning electron microscopy study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of surface-active agents in drug absorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All aboard for octreotide

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nasal absorption of insulin: enhancement by hydrophobic bile salts

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of SMS 201-995 in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic criteria for the evaluation of retard formulations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1589410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1018927710280

1 reference

Europe PubMed Central

24 July 2017

1 reference

Europe PubMed Central

24 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33215101&oldid=1633833959"